Penn Foundation

Penn Foundation

Services:
Type of Care
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Recovery Support Services

• Self-help groups
• Employment counseling or training
• Housing services
• Assistance with obtaining social services
• Mentoring/peer support

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Testing

• TB screening
• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing
• Drug and alcohol oral fluid testing

Language Services

• Sign language services for the deaf and hard of hearing

Age Groups Accepted

• Young Adults
• Adults

Treatment Approaches

• 12-step facilitation
• Anger management
• Relapse prevention
• Trauma-related counseling
• Telemedicine/telehealth therapy
• Substance use disorder counseling
• Cognitive behavioral therapy
• Motivational interviewing

Pharmacotherapies

• Clonidine
• Medication for mental disorders
• Buprenorphine (extended-release, injectable)
• Acamprosate (Campral®)
• Nicotine replacement
• Naltrexone (oral)
• Buprenorphine with naloxone
• Disulfiram
• Non-nicotine smoking/tobacco cessation
• Buprenorphine without naloxone
• Naltrexone (extended-release, injectable)

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Outcome follow-up after discharge
• Aftercare/continuing care

Facility Vaping Policy

• Vaping not permitted

Payment/Insurance/Funding Accepted

• Medicaid
• Cash or self-payment
• Private health insurance
• State-financed health insurance plan other than Medicaid

External Opioid Medications Source

• Other contracted prescribing entity
• No formal relationship with prescribing entity
• In-network prescribing entity

Assessment/Pre-treatment

• Interim services for clients
• Screening for substance use
• Outreach to persons in the community
• Comprehensive mental health assessment
• Screening for mental disorders
• Comprehensive substance use assessment

Facility Smoking Policy

• Smoking permitted in designated area

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• Other contracted prescribing entity
• No formal relationship with prescribing entity

Ancillary Services

• Social skills development
• Case management service

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Education and Counseling Services

• Substance use disorder education
• Family counseling
• Health education services other than HIV/AIDS or hepatitis
• HIV or AIDS education, counseling, or support
• Hepatitis education, counseling, or support
• Group counseling
• Individual counseling

License/Certification/Accreditation

• State Substance use treatment agency

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine maintenance
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Accepts clients using MAT but prescribed elsewhere

Gender Accepted

• Female
• Male

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Intensive outpatient treatment
• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment